OR WAIT null SECS
Patricia Van Arnum was executive editor of Pharmaceutical Technology.
February 12, 2010
Personalized medicine is still a nascent area for the pharmaceutical company, but several large pharmaceutical companies recently reported on developments in this area.
February 11, 2010
Personalized medicine is still a nascent area for pharmaceutical companies, but several large companies recently reported developments in this area.
GSK Chief Executive Andrew Witty outlined the company's strategic priorities for 2010, which include further diversification into emerging markets, consumer healthcare, and vaccines.
February 05, 2010
AstraZeneca plans to undertake further restructuring in its R&D operations, resulting in the elimination of 3500 jobs.
February 04, 2010
AstraZeneca announced this week that it plans to undertake further restructuring in its research and development operations, resulting in the elimination of 3500 jobs.
February 03, 2010
Growth in emerging markets and across the generic-drug sector shifts the global demand and supply of active pharmaceutical ingredients.